Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brockstein

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|June 7, 2000
Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?B Brockstein
Lancet (London, England)|November 21, 2000
Benefits of chemotherapy in head and neck cancerB Brockstein
Annals of Vascular Surgery|July 1, 1994
Blood supply to the spinal cord: anatomic and physiologic correlationsB Brockstein, L Johns, B L Gewertz
Investigational New Drugs|August 25, 2000
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancerT Lad, F Rosen, D Sciortino, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 18, 2000
Swallowing function in patients with head and neck cancer prior to treatmentK M Stenson, E MacCracken, M List, et al.
Investigational New Drugs|September 20, 2001
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerB Brockstein, B Samuels, R Humerickhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancerB Brockstein, D J Haraf, K Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancerR A Humerickhouse, M E Dolan, D J Haraf, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Head & Neck|November 24, 1999
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directionsG T Wolf, A Forastiere, K Ang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|June 7, 2000
Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?B Brockstein
Lancet (London, England)|November 21, 2000
Benefits of chemotherapy in head and neck cancerB Brockstein
Annals of Vascular Surgery|July 1, 1994
Blood supply to the spinal cord: anatomic and physiologic correlationsB Brockstein, L Johns, B L Gewertz
Investigational New Drugs|August 25, 2000
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancerT Lad, F Rosen, D Sciortino, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 18, 2000
Swallowing function in patients with head and neck cancer prior to treatmentK M Stenson, E MacCracken, M List, et al.
Investigational New Drugs|September 20, 2001
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerB Brockstein, B Samuels, R Humerickhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancerB Brockstein, D J Haraf, K Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancerR A Humerickhouse, M E Dolan, D J Haraf, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Head & Neck|November 24, 1999
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directionsG T Wolf, A Forastiere, K Ang, et al.
Pageof 2